Zenith Healthcare (BOM:530665) Stock Based Compensation: ₹0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530665 Zenith Healthcare Ltd BOM:530665
61 GF Score
Price ₹3.10
GF Value ₹3.71
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Zenith Healthcare Stock Based Compensation?

Zenith Healthcare BOM:530665 -1.27% 61 Stock Based Compensation is ₹0.0 Mil as of Jun. 2026. GuruFocus rates BOM:530665 with a GF Score™ of 61/100 and a GF Value™ of ₹3.71 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Zenith Healthcare's Stock Based Compensation for the three months ended in Jun. 2026 was ₹0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 was ₹0.0 Mil.

Zenith Healthcare Stock Based Compensation Related Terms

Zenith Healthcare Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Zenith Healthcare's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenith Healthcare Stock Based Compensation Chart

Zenith Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Zenith Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:530665
61GF Score
Zenith Healthcare Ltd BOM:530665
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenith Healthcare Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

What does a Stock Based Compensation of ₹0.0 Mil mean?
Zenith Healthcare (BOM:530665) has a Stock Based Compensation of ₹0.0 Mil as of Jun. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Zenith Healthcare and its competitors.
Is Zenith Healthcare's Stock Based Compensation too high?
Zenith Healthcare's current Stock Based Compensation is ₹0.0 Mil. Overall, Zenith Healthcare has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zenith Healthcare's Stock Based Compensation compare to ZTS?
Zenith Healthcare's Stock Based Compensation of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Drug Manufacturers company?
A good Stock Based Compensation depends on the Drug Manufacturers industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Zenith Healthcare and its competitors. Zenith Healthcare's current Stock Based Compensation is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenith Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Zenith Healthcare (BOM:530665) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹3.71, compared to a current price of ₹3.10 — trading 16.4% below its estimated fair value. The current Stock Based Compensation is ₹0.0 Mil. Zenith Healthcare's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Zenith Healthcare (BOM:530665), the current Stock Based Compensation is ₹0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zenith Healthcare (BOM:530665) Overvalued in 2026?

Based on GuruFocus' analysis, Zenith Healthcare stock appears to be undervalued. The current stock price of ₹3.10 is trading 16.4% below its estimated GF Value™ of ₹3.71. GuruFocus considers Zenith Healthcare to be Modestly Undervalued.

Key valuation signals for BOM:530665:

  • Stock Based Compensation: ₹0.0 Mil
  • GF Value™: ₹3.71 vs. price of ₹3.10 (16.4% below fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the BOM:530665 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zenith Healthcare Business Description

Address Prahladnagar Cross Road, S. G. Road, 504, Iscon Elegance, Near Ananddham Jain Derasar, Ahmedabad, GJ, IND, 380051
Zenith Healthcare Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and trading of pharmaceutical formulations. The company also undertakes contracts for manufacturing business. It manufactures pharmaceutical formulations in the form of Tablets, Capsules, Oral liquids, and injectables. The company sells its products in India and also exports internationally.
61GF Score

Get the complete analysis for BOM:530665

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3.10
Price
₹3.71
GF Value